A naturally occurring Tat R52W variant in brain-derived HIV attenuates transcription and may contribute to reservoir persistence
- 1Department of Biochemistry and Biophysics and the UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 27599
Abstract
HIV-1 persistence under suppressive antiretroviral therapy (ART) remains a major barrier to eradication, yet the contribution of naturally occurring viral variation to transcriptional regulation is incompletely understood. Here, we identify an HIV-1 Tat variant (R52W) that attenuates viral transcription through the disruption of the Tat-TAR RNA interaction. Full-length HIV-1 genomes derived from the brain microglia of a Last Gift donor, together with peripheral viral sequences obtained during suppressive ART, revealed the presence of the R52W variant in vivo. The same R52W variant was found in another virally suppressed donor within the same cohort. Additional analysis of 3,440 clinical blood isolates from people with HIV identified R52W in 73 sequences (2.12%) of individuals, including three on ART and a therapy controller, and across diverse viral subtypes. Structural modeling demonstrated that R52W destabilizes Tat-TAR binding, while functional assays showed markedly reduced Tat-mediated transcriptional activity, which was restored upon tryptophan-to-arginine reversion (W52R) in Tat. These findings establish a direct molecular mechanism by which a naturally occurring HIV-1 variant modulates viral transcriptional output. Together, our results identify transcriptionally attenuated HIV-1 variants in treated individuals and suggest that modulation of Tat-dependent transcription may represent an underappreciated determinant of viral persistence under suppressive ART.
Related
- Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults
- Naturally Occurring Variability in the Regulatory Region of the Drosophila melanogaster Gene shuttle craft Affects Gene Expression and Lifespan
- Milk metabolomic signatures associated with naturally occurring Staphylococcus chromogenes subclinical mastitis in early-lactation dairy cows.
- Food additive and naturally occurring glutamate and risk of cardiovascular diseases in the NutriNet-Santé prospective cohort
- Multiple domains of Mata1 transcription factor contribute to binding site specificity
BibTeX
@misc{chen2026naturally,
title = {{A naturally occurring Tat R52W variant in brain-derived HIV attenuates transcription and may contribute to reservoir persistence}},
author = {H. Chen and N. Jiang and Y. Tang and A. Chaillon and S. Gianella and D. M. Margolis and V. R. Chirasani and G. Jiang},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.22.753475},
url = {https://www.biorxiv.org/content/10.64898/2026.09.22.753475v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - A naturally occurring Tat R52W variant in brain-derived HIV attenuates transcription and may contribute to reservoir persistence
AU - H. Chen
AU - N. Jiang
AU - Y. Tang
AU - A. Chaillon
AU - S. Gianella
AU - D. M. Margolis
AU - V. R. Chirasani
AU - G. Jiang
PY - 2026
DA - 2026/09/22
PB - bioRxiv
DO - 10.64898/2026.09.22.753475
UR - https://www.biorxiv.org/content/10.64898/2026.09.22.753475v1
AB - HIV-1 persistence under suppressive antiretroviral therapy (ART) remains a major barrier to eradication, yet the contribution of naturally occurring viral variation to transcriptional regulation is incompletely understood. Here, we identify an HIV-1 Tat variant (R52W) that attenuates viral transcription through the disruption of the Tat-TAR RNA interaction. Full-length HIV-1 genomes derived from the brain microglia of a Last Gift donor, together with peripheral viral sequences obtained during suppressive ART, revealed the presence of the R52W variant in vivo. The same R52W variant was found in another virally suppressed donor within the same cohort. Additional analysis of 3,440 clinical blood isolates from people with HIV identified R52W in 73 sequences (2.12%) of individuals, including three on ART and a therapy controller, and across diverse viral subtypes. Structural modeling demonstrated that R52W destabilizes Tat-TAR binding, while functional assays showed markedly reduced Tat-mediated transcriptional activity, which was restored upon tryptophan-to-arginine reversion (W52R) in Tat. These findings establish a direct molecular mechanism by which a naturally occurring HIV-1 variant modulates viral transcriptional output. Together, our results identify transcriptionally attenuated HIV-1 variants in treated individuals and suggest that modulation of Tat-dependent transcription may represent an underappreciated determinant of viral persistence under suppressive ART.
ER -